"Pharmaceutical products and chemicals are the bloc’s No. 1 export to America. Among them are the weight-loss blockbuster Ozempic, cancer treatments, cardiovascular drugs and flu vaccines. Most are name-brand drugs that yield a large profit in the American market, with its high prices and vast numbers of consumers.
“These are critical things that keep people alive,” said Léa Auffret, who heads international affairs for BEUC, the European Consumer Organization. “Putting them in the middle of a trade war is highly concerning.”
European companies could react to Mr. Trump’s tariffs in a range of ways. Some pharmaceutical companies trying to dodge the tariffs have already announced plans to increase production in the United States, which Mr. Trump wants. Others could decide to move production there later.
Other companies appear to be staying put, but could raise their prices to cover the tariffs, pushing up costs for patients. And higher prices could affect not only American consumers, but also patients in Europe. Some companies have begun to argue that Europe should create more favorable conditions for their businesses by dismantling some of the rules that keep drug prices down.
Or some middle ground could play out: Companies might shift their financial profits to the United States for accounting purposes to avoid import charges, even as they leave their physical factories overseas to avoid the expenses of moving and challenges of having to set up new supply chains."
https://www.nytimes.com/2025/04/27/world/europe/tariffs-pharmaceuticals-drugs-medicine-trump.html
sufficiently, it will become feasible to conduct a number of industrial processes in 
, because of the absence of 
Lactic acid bacteria can improve plant-based dairy alternatives
Cells very similar to neurons obtained from human dental stem cells
Acoustic levitation of diamond inspires biotech automation innovation
Un campus biotech continue de pousser rue Saint-Urbain
RNA interference and nanomedicine join forces to fight dangerous fungal infections
Engineered yeast boosts D-lactic acid production, advancing eco-friendly biomanufacturing
Making food from our organic waste may not be as good an idea as first thought